S&P 500   0.62 (-3.91%)
DOW   0.62 (-3.91%)
QQQ   260.37 (+0.71%)
AAPL   388.23 (+1.65%)
MSFT   208.35 (+0.62%)
FB   239.73 (+0.31%)
GOOGL   1,520.86 (+0.57%)
AMZN   3,084.00 (-0.64%)
NVDA   415.08 (+3.23%)
CGC   17.38 (+0.46%)
BABA   248.58 (-1.23%)
MU   49.71 (+0.51%)
GE   6.88 (+2.69%)
TSLA   1,516.80 (+1.32%)
AMD   54.72 (+2.11%)
T   29.96 (+0.64%)
ACB   11.75 (-2.73%)
F   6.36 (+4.78%)
GILD   77.19 (+0.67%)
DIS   118.66 (+2.08%)
NFLX   524.88 (-0.12%)
BAC   24.14 (-0.21%)
BA   179.96 (+2.45%)
S&P 500   0.62 (-3.91%)
DOW   0.62 (-3.91%)
QQQ   260.37 (+0.71%)
AAPL   388.23 (+1.65%)
MSFT   208.35 (+0.62%)
FB   239.73 (+0.31%)
GOOGL   1,520.86 (+0.57%)
AMZN   3,084.00 (-0.64%)
NVDA   415.08 (+3.23%)
CGC   17.38 (+0.46%)
BABA   248.58 (-1.23%)
MU   49.71 (+0.51%)
GE   6.88 (+2.69%)
TSLA   1,516.80 (+1.32%)
AMD   54.72 (+2.11%)
T   29.96 (+0.64%)
ACB   11.75 (-2.73%)
F   6.36 (+4.78%)
GILD   77.19 (+0.67%)
DIS   118.66 (+2.08%)
NFLX   524.88 (-0.12%)
BAC   24.14 (-0.21%)
BA   179.96 (+2.45%)
S&P 500   0.62 (-3.91%)
DOW   0.62 (-3.91%)
QQQ   260.37 (+0.71%)
AAPL   388.23 (+1.65%)
MSFT   208.35 (+0.62%)
FB   239.73 (+0.31%)
GOOGL   1,520.86 (+0.57%)
AMZN   3,084.00 (-0.64%)
NVDA   415.08 (+3.23%)
CGC   17.38 (+0.46%)
BABA   248.58 (-1.23%)
MU   49.71 (+0.51%)
GE   6.88 (+2.69%)
TSLA   1,516.80 (+1.32%)
AMD   54.72 (+2.11%)
T   29.96 (+0.64%)
ACB   11.75 (-2.73%)
F   6.36 (+4.78%)
GILD   77.19 (+0.67%)
DIS   118.66 (+2.08%)
NFLX   524.88 (-0.12%)
BAC   24.14 (-0.21%)
BA   179.96 (+2.45%)
S&P 500   0.62 (-3.91%)
DOW   0.62 (-3.91%)
QQQ   260.37 (+0.71%)
AAPL   388.23 (+1.65%)
MSFT   208.35 (+0.62%)
FB   239.73 (+0.31%)
GOOGL   1,520.86 (+0.57%)
AMZN   3,084.00 (-0.64%)
NVDA   415.08 (+3.23%)
CGC   17.38 (+0.46%)
BABA   248.58 (-1.23%)
MU   49.71 (+0.51%)
GE   6.88 (+2.69%)
TSLA   1,516.80 (+1.32%)
AMD   54.72 (+2.11%)
T   29.96 (+0.64%)
ACB   11.75 (-2.73%)
F   6.36 (+4.78%)
GILD   77.19 (+0.67%)
DIS   118.66 (+2.08%)
NFLX   524.88 (-0.12%)
BAC   24.14 (-0.21%)
BA   179.96 (+2.45%)
Log in

NYSE:BMYBristol-Myers Squibb News Headlines

$57.89
+0.14 (+0.24 %)
(As of 07/14/2020 04:00 PM ET)
Add
Compare
Today's Range
$57.29
Now: $57.89
$58.10
50-Day Range
$55.10
MA: $58.68
$61.43
52-Week Range
$42.48
Now: $57.89
$68.34
Volume12.15 million shs
Average Volume15.94 million shs
Market Capitalization$130.99 billion
P/E Ratio71.47
Dividend Yield3.12%
Beta0.73

Headlines

Bristol-Myers Squibb (NYSE BMY) News Headlines

Source:
DateHeadline
Bristol-Myers Squibb loses inventorship fight with Boston cancer instituteBristol-Myers Squibb loses inventorship fight with Boston cancer institute
www.reuters.com - July 14 at 7:28 PM
ReviveMed Announces AI-driven Metabolomics Study with Bristol Myers SquibbReviveMed Announces AI-driven Metabolomics Study with Bristol Myers Squibb
www.marketwatch.com - July 14 at 2:27 PM
Why Bristol-Myers Squibb (BMY) Stock is a Compelling Investment CaseWhy Bristol-Myers Squibb (BMY) Stock is a Compelling Investment Case
finance.yahoo.com - July 14 at 2:27 PM
Got $5,000? Smart Investors Are Piling Into These StocksGot $5,000? Smart Investors Are Piling Into These Stocks
www.fool.com - July 14 at 9:26 AM
Protein Phosphatase 2A Market Predictive Business Strategy Amidst COVID-19 Impact Analysis Summary (2020-2029)Protein Phosphatase 2A Market Predictive Business Strategy Amidst COVID-19 Impact Analysis Summary (2020-2029)
www.marketwatch.com - July 13 at 8:24 AM
Pfizer Surges On First Coronavirus Vaccine Test — But Is PFE Stock A Buy?Pfizer Surges On First Coronavirus Vaccine Test — But Is PFE Stock A Buy?
finance.yahoo.com - July 13 at 8:24 AM
Notable ETF Outflow Detected - XLV, PFE, AMGN, BMYNotable ETF Outflow Detected - XLV, PFE, AMGN, BMY
www.nasdaq.com - July 10 at 1:07 PM
Bristol Myers (BMY) Moves to Strong Buy: Rationale Behind the UpgradeBristol Myers (BMY) Moves to Strong Buy: Rationale Behind the Upgrade
www.nasdaq.com - July 9 at 2:44 PM
Is Bristol-Myers Squibb A Better Bet Than Amgen?Is Bristol-Myers Squibb A Better Bet Than Amgen?
www.forbes.com - July 9 at 9:44 AM
Bristol-Myers Squibb Companys (NYSE:BMY) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?Bristol-Myers Squibb Company's (NYSE:BMY) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
finance.yahoo.com - July 9 at 9:44 AM
Bristol-Myers Squibb Company's (NYSE:BMY) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?Bristol-Myers Squibb Company's (NYSE:BMY) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
finance.yahoo.com - July 9 at 9:44 AM
Kitov Pharma Receives Notice of Intention to Grant a European Patent Covering CM24, its anti-CEACAM1 AntibodyKitov Pharma Receives Notice of Intention to Grant a European Patent Covering CM24, its anti-CEACAM1 Antibody
www.benzinga.com - July 8 at 8:27 AM
Lithium Medication Market 2020 Industry Size, Share, Future Challenges, Explosive Growth Opportunity and Regional Analysis and Forecast to 2024Lithium Medication Market 2020 Industry Size, Share, Future Challenges, Explosive Growth Opportunity and Regional Analysis and Forecast to 2024
www.marketwatch.com - July 8 at 8:27 AM
Bristol Myers Squibb (BMY) Gains As Market Dips: What You Should KnowBristol Myers Squibb (BMY) Gains As Market Dips: What You Should Know
finance.yahoo.com - July 7 at 10:07 PM
Top Stock Reports for Alibaba, NVIDIA & Bristol Myers SquibbTop Stock Reports for Alibaba, NVIDIA & Bristol Myers Squibb
finance.yahoo.com - July 7 at 5:06 PM
Dragonfly Therapeutics Picks Up $55 Million With Bristol-Myers DealDragonfly Therapeutics Picks Up $55 Million With Bristol-Myers Deal
www.wsj.com - July 6 at 10:52 PM
BRIEF-Dragonfly Therapeutics Announces Research Collaboration With Bristol Myers SquibbBRIEF-Dragonfly Therapeutics Announces Research Collaboration With Bristol Myers Squibb
www.reuters.com - July 6 at 12:51 PM
Bristol-Myers Squibb Co (NYSE:BMY) Expected to Announce Quarterly Sales of $9.97 BillionBristol-Myers Squibb Co (NYSE:BMY) Expected to Announce Quarterly Sales of $9.97 Billion
www.americanbankingnews.com - July 4 at 4:12 AM
Bristol Myers Squibb: Insider Anticipating Significant Shareholder Value Creation From MergerBristol Myers Squibb: Insider Anticipating Significant Shareholder Value Creation From Merger
seekingalpha.com - July 2 at 1:10 PM
William Blair Comments on Bristol-Myers Squibb Cos Q2 2020 Earnings (NYSE:BMY)William Blair Comments on Bristol-Myers Squibb Co's Q2 2020 Earnings (NYSE:BMY)
www.americanbankingnews.com - July 2 at 8:25 AM
$1.46 Earnings Per Share Expected for Bristol-Myers Squibb Co (NYSE:BMY) This Quarter$1.46 Earnings Per Share Expected for Bristol-Myers Squibb Co (NYSE:BMY) This Quarter
www.americanbankingnews.com - July 2 at 5:59 AM
Is Bristol Myers (BMY) a Solid Growth Stock? 3 Reasons to Think " YesIs Bristol Myers (BMY) a Solid Growth Stock? 3 Reasons to Think " Yes
www.nasdaq.com - July 1 at 2:38 PM
Is Bristol Myers (BMY) a Solid Growth Stock? 3 Reasons to Think " Yes "Is Bristol Myers (BMY) a Solid Growth Stock? 3 Reasons to Think " Yes "
finance.yahoo.com - July 1 at 2:37 PM
Global Dasatinib Drugs Market 2020 By Segment Forecasts 2025 | Bristol-Myers Squibb, LUCIUS Pharma, etc.Global Dasatinib Drugs Market 2020 By Segment Forecasts 2025 | Bristol-Myers Squibb, LUCIUS Pharma, etc.
www.marketwatch.com - July 1 at 9:37 AM
Q1 2021 EPS Estimates for Bristol-Myers Squibb Co (NYSE:BMY) Boosted by AnalystQ1 2021 EPS Estimates for Bristol-Myers Squibb Co (NYSE:BMY) Boosted by Analyst
www.americanbankingnews.com - July 1 at 7:30 AM
Bristol-Myers Squibb Co (NYSE:BMY) Declares $0.45 Quarterly DividendBristol-Myers Squibb Co (NYSE:BMY) Declares $0.45 Quarterly Dividend
www.marketbeat.com - June 30 at 8:27 AM
Canada federal court dismisses drugmakers' plea challenging drug price rulesCanada federal court dismisses drugmakers' plea challenging drug price rules
finance.yahoo.com - June 29 at 7:15 PM
Were Hedge Funds Right About Piling Into Bristol Myers Squibb Company (BMY)?Were Hedge Funds Right About Piling Into Bristol Myers Squibb Company (BMY)?
finance.yahoo.com - June 29 at 2:15 PM
Is Bristol Myers Squibb (BMY) a Great Value Stock Right Now?Is Bristol Myers Squibb (BMY) a Great Value Stock Right Now?
finance.yahoo.com - June 29 at 2:15 PM
Bristol-Myers Squibb Company (BMY) CEO Giovanni Caforio on Special Call (Transcript)Bristol-Myers Squibb Company (BMY) CEO Giovanni Caforio on Special Call (Transcript)
seekingalpha.com - June 26 at 6:31 PM
Bristol-Myers Squibb Co (NYSE:BMY) Given Consensus Rating of "Buy" by AnalystsBristol-Myers Squibb Co (NYSE:BMY) Given Consensus Rating of "Buy" by Analysts
www.americanbankingnews.com - June 26 at 1:09 PM
Bristol-Myers Squibb Company (BMY) CEO Giovanni Caforio Hosts Investor Series - Hematology Conference Call (Transcript)Bristol-Myers Squibb Company (BMY) CEO Giovanni Caforio Hosts Investor Series - Hematology Conference Call (Transcript)
seekingalpha.com - June 25 at 9:23 PM
3 Reasons Bristol-Myers Squibb Could Make You Rich3 Reasons Bristol-Myers Squibb Could Make You Rich
seekingalpha.com - June 25 at 8:24 AM
Bristol’s Pipeline of Cancer Drugs Could Bring Sales of $20 Billion. Thanks Celgene.Bristol’s Pipeline of Cancer Drugs Could Bring Sales of $20 Billion. Thanks Celgene.
finance.yahoo.com - June 24 at 7:02 PM
Why Is Everyone Talking About Bristol Myers Squibb Stock?Why Is Everyone Talking About Bristol Myers Squibb Stock?
www.fool.com - June 24 at 9:00 AM
Bristol Myers Squibb (BMY) Outpaces Stock Market Gains: What You Should KnowBristol Myers Squibb (BMY) Outpaces Stock Market Gains: What You Should Know
finance.yahoo.com - June 23 at 10:59 PM
Bristol Myers Squibb Offers Growth With A Safe DividendBristol Myers Squibb Offers Growth With A Safe Dividend
seekingalpha.com - June 23 at 5:58 PM
Bristol Myers Squibb (BMY) is a Top Dividend Stock Right Now: Should You Buy? (Revised)Bristol Myers Squibb (BMY) is a Top Dividend Stock Right Now: Should You Buy? (Revised)
www.nasdaq.com - June 23 at 5:58 PM
Top Ranked Growth Stocks to Buy for June 23rdTop Ranked Growth Stocks to Buy for June 23rd
finance.yahoo.com - June 23 at 12:58 PM
Top Buys By Directors: Paliwals $500K Bet On BMYTop Buys By Directors: Paliwal's $500K Bet On BMY
www.forbes.com - June 22 at 12:29 PM
Bullish US Stocks With Healthy Quarterly Performance: $BMY $XPO $DBXBullish US Stocks With Healthy Quarterly Performance: $BMY $XPO $DBX
www.marketwatch.com - June 19 at 12:25 PM
Why Growth Investors will Love These 2 Healthcare StocksWhy Growth Investors will Love These 2 Healthcare Stocks
finance.yahoo.com - June 19 at 12:25 PM
Cancer Biotherapy Market Analysis 2020 Along with Research Report 2026 | Amgen(NASDAQ: AMGN), Bristol-Myers Squibb, CelgeneCancer Biotherapy Market Analysis 2020 Along with Research Report 2026 | Amgen(NASDAQ: AMGN), Bristol-Myers Squibb, Celgene
www.marketwatch.com - June 19 at 7:25 AM
3 Low Forward Price-Earnings Ratio Stocks for the Value Investor3 Low Forward Price-Earnings Ratio Stocks for the Value Investor
finance.yahoo.com - June 18 at 3:10 PM
Vidence, LLC Launched to Set Standard for High-Quality Cancer Data, Research and AnalyticsVidence, LLC Launched to Set Standard for High-Quality Cancer Data, Research and Analytics
finance.yahoo.com - June 18 at 3:10 PM
ArcherDX Enters Collaboration with Bristol Myers Squibb to Apply Personalized Cancer Monitoring (PCM™) to Clinical ResearchArcherDX Enters Collaboration with Bristol Myers Squibb to Apply Personalized Cancer Monitoring (PCM™) to Clinical Research
www.prnewswire.com - June 18 at 10:10 AM
Bristol Myers Squibb to Announce Results for Second Quarter 2020 on August 6, 2020Bristol Myers Squibb to Announce Results for Second Quarter 2020 on August 6, 2020
finance.yahoo.com - June 18 at 10:10 AM
Bristol-myers Squibb Co passes this 3-point dividend checklistBristol-myers Squibb Co passes this 3-point dividend checklist
uk.finance.yahoo.com - June 17 at 11:16 PM
Bristol-Myers initiates debt exchange offersBristol-Myers initiates debt exchange offers
seekingalpha.com - June 16 at 5:00 PM
Bristol Myers initiates registered exchange offersBristol Myers initiates registered exchange offers
seekingalpha.com - June 16 at 12:00 PM
This page was last updated on 7/14/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.